GOLDENWELL BIOTECH, INC. Quarterly Revenues in USD from Q3 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Goldenwell Biotech, Inc. quarterly/annual Revenues history and growth rate from Q3 2019 to Q4 2022.
  • Goldenwell Biotech, Inc. Revenues for the quarter ending December 31, 2022 was $0.000.
  • Goldenwell Biotech, Inc. annual Revenues for 2022 was $47.8K, a 199% increase from 2021.
  • Goldenwell Biotech, Inc. annual Revenues for 2021 was $16K.
  • Goldenwell Biotech, Inc. annual Revenues for 2020 was $0.000.
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-04-13
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-08-05
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-02-23
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-05
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2021-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.